myricxpharma.com
Open in
urlscan Pro
84.18.203.45
Public Scan
Submitted URL: http://myricxpharma.com/
Effective URL: https://myricxpharma.com/
Submission: On November 04 via api from US — Scanned from GB
Effective URL: https://myricxpharma.com/
Submission: On November 04 via api from US — Scanned from GB
Form analysis
0 forms found in the DOMText Content
image/svg+xml * Home * About Us * Management Team * Roberto Solari * Professor Ed Tate * Grant Hawthorne * Nikki D’Arcy * Josephine Walton * Ateequllah Hayat * Robin Carr * Andrew Bell * Board of Directors * Collaborators * Investors * Science * Our Programmes * Publications and Presentations * Media Centre * News * Events * Contact Us * Menu Menu WORLD LEADERS IN THE TRANSLATION OF NMT SCIENCE INTO PROMISING NEW PRECISION MEDICINES WORLD LEADERS IN THE TRANSLATION OF NMT SCIENCE INTO PROMISING NEW PRECISION MEDICINES ABOUT MYRICX We are a drug discovery company selectively targeting protein myristoylation for the treatment of a wide range of diseases including cancer and viral infections. Learn more SCIENCE Based on our world leading research into the structure and biology of N-myristoyltransferase (NMT), the key enzyme in protein myristoylation we have made highly potent and selective small molecule inhibitors of this enzyme. Learn more TEAM Led by a team of internationally renowned scientists and drug developers with an outstanding track record of commercial and academic successes. Learn more OUR PURPOSE To unlock the potential of N-myristoyltransferase (NMT) as a therapeutic target and develop precision medicines for a range of diseases with unmet medical need including cancer and viral infections. HIGH-RESOLUTION SNAPSHOTS OF HUMAN N-MYRISTOYLTRANSFERASE IN ACTION View video LATEST NEWS * Myricx Pharma Announces Senior Team Expansion with Appointment of CMO, and Heads of Biology and Bioinformatics 22 February 2022 - Zahid Bashir MB BS, MSc joins as Chief Medical Officer, bringing significant clinical haematology and oncology experience, having led the… * Myricx Pharma Announces Board and Executive Appointments 20 April 2021 - Rachael Brake, PhD joins the board as independent non-executive director, bringing significant drug development experience, notably from Takeda, Amgen, Millennium… View publications Myricx Pharma Limited 125 Wood Street, London, EC2V 7AW * Privacy Policy * Scroll to top